Friday 26th September 2008 |
Text too small? |
IRG sees "significant" synergies with Ellerie, said managing director Brent King, in a statement. No price was given.
IRG stock, which trades infrequently, changed hands at 5 cents today and has declined 75% this year. The company posted a full-year loss of NZ$15.2 million loss after a slump in the value of its investments in Dorchester Pacific investment and ICP Biotechnology, which was placed in receivership.
Last month, the company named former Finance Minister Bill Birch as chairman, taking over from King, who stayed on as managing director.
Compare
deposit rates and view special rates online or sign up to the Deposit Rates news alerts. |
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors